Metabolic Dysfunction-associated Steatotic Liver Disease Trials in Spain, 2026
Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.
About this register
This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,909 studies in total at the last sync on 17 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.
This page shows the 8 of those studies listing the condition Metabolic Dysfunction-associated Steatotic Liver Disease.
How many Metabolic Dysfunction-associated Steatotic Liver Disease trials are recruiting in Spain?
3 of the 8 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.
Summary by phase
| Phase | Studies | Recruiting | Share |
|---|---|---|---|
| Not applicable | 3 | 0 | 37.5% |
| Observational | 3 | 2 | 37.5% |
| Phase 3 | 2 | 1 | 25% |
Most active sponsors
| Lead sponsor | Studies | Recruiting |
|---|---|---|
| Boehringer Ingelheim | 1 | 0 |
| Eli Lilly and Company | 1 | 1 |
| Hospital General Universitario Gregorio Marañon | 1 | 1 |
| Hospital Universitari de Bellvitge | 1 | 0 |
| Hospital Universitari Vall d'Hebron Research Institute | 1 | 0 |
| Novartis Pharmaceuticals | 1 | 1 |
| Universidad de Almeria | 1 | 0 |
| University Rovira i Virgili | 1 | 0 |